Freer Alice, Williams Felicity R, Durman Simon, Hayden Jennifer, Armstrong Matthew J, Trivedi Palak J
National Institute of Health Research (NIHR) Birmingham Biomedical Research Centre (BRC), Centre for Liver and Gastrointestinal Research, University of Birmingham, Birmingham, UK.
Liver Unit, University Hospitals Birmingham Queen Elizabeth. Birmingham UK.
JHEP Rep. 2024 Sep 6;6(12):101210. doi: 10.1016/j.jhepr.2024.101210. eCollection 2024 Dec.
BACKGROUND & AIMS: Fatigue is a commonly reported symptom of primary biliary cholangitis (PBC). We conducted a single-arm, open-label clinical trial to assess the efficacy of a physiotherapist-led home-based exercise programme (HBEP) in patients with PBC and moderate-to-severe fatigue (NCT04265235).
A 12-week individualised HBEP (aerobic + resistance based) was delivered to patients with a PBC-40 fatigue domain score ≥33. The primary efficacy outcome measure was a reduction in fatigue severity by ≥5 points. Secondary outcome measures included other domains of PBC-40, the FIS (fatigue impact scale), ESS (Epworth sleepiness score), HADS (hospital anxiety and depression scale), aerobic capacity (ISWT [incremental shuttle walk test], Duke activity status index (predicted VO₂ peak) and physical function (short physical performance battery [SPPB]).
A total of 31 patients were recruited, of whom 30 completed the 12-week HBEP (29 women; median age 53 years, median alkaline phosphatase value: 1.5x the upper limit of normal, median bilirubin: 12 μmol/L, and median baseline PBC-40 fatigue score 42). The primary outcome was met by 26 patients, with a median reduction in PBC-40 fatigue score of -10.5 points (IQR -9 to -13; 0.001). Reductions were also observed in the symptom, cognition, and emotion domains of PBC-40, and in the FIS, ESS and HADS (0.01 for all measures). This was alongside increases in the median ISWT (+90 m; IQR 57.5-110), predicted VO₂ peak (+2.41 ml/kg/min; IQR 0.01-4.05), and SPPB (+1 point; IQR 0-1.4) (all 0.001). 28 participants achieved the maximum SPPB score of 12/12 ( 13 patients at baseline; 0.001). No significant adverse events were reported.
This proof-of-concept study shows that a HBEP is safe, feasible, and has the potential to attenuate fatigue. Controlled trials are needed to validate the efficacy of exercise interventions in PBC.
Fatigue is a common symptom in primary biliary cholangitis (PBC), and is linked to cognitive dysfunction, somnolence, and reduced activity. The pathogenesis is multifactorial, and muscle bioenergetic abnormalities have been proposed to contribute. In this study, we show that a home-based exercise programme, consisting of aerobic and resistance-based sets, can be safely delivered to people living with PBC. In addition, the programme led to a reduction in fatigue severity, less daytime sleepiness and improved cognitive function.
疲劳是原发性胆汁性胆管炎(PBC)常见的症状。我们开展了一项单臂、开放标签的临床试验,以评估由物理治疗师指导的居家锻炼计划(HBEP)对患有PBC且有中度至重度疲劳的患者的疗效(NCT04265235)。
对PBC-40疲劳领域评分≥33的患者实施为期12周的个性化HBEP(有氧运动+抗阻运动)。主要疗效指标是疲劳严重程度降低≥5分。次要指标包括PBC-40的其他领域、疲劳影响量表(FIS)、爱泼沃斯嗜睡量表(ESS)、医院焦虑抑郁量表(HADS)、有氧运动能力(递增穿梭步行试验[ISWT]、杜克活动状态指数[预测的VO₂峰值])以及身体功能(简短身体性能量表[SPPB])。
共招募了31例患者,其中30例完成了为期12周的HBEP(29例女性;中位年龄53岁,中位碱性磷酸酶值:正常上限的1.5倍,中位胆红素:12μmol/L,基线时PBC-40疲劳评分中位数为42)。26例患者达到主要终点,PBC-40疲劳评分中位数降低了-10.5分(四分位间距-9至-13;P<0.001)。PBC-40的症状、认知和情感领域以及FIS、ESS和HADS也有降低(所有指标P<0.01)。与此同时,ISWT中位数增加(+90米;四分位间距57.5-110)、预测的VO₂峰值增加(+2.41毫升/千克/分钟;四分位间距0.01-4.05)以及SPPB增加(+1分;四分位间距0-1.4)(所有指标P<0.001)。28名参与者达到了SPPB的最高分数12/12(13例患者基线时达到;P<0.001)。未报告显著不良事件。
这项概念验证研究表明,HBEP是安全、可行的,并且有可能减轻疲劳。需要进行对照试验来验证运动干预对PBC的疗效。
疲劳是原发性胆汁性胆管炎(PBC)的常见症状,与认知功能障碍、嗜睡和活动减少有关。其发病机制是多因素的,有人提出肌肉生物能量异常起作用。在本研究中,我们表明,由有氧运动和抗阻运动组成的居家锻炼计划可以安全地提供给PBC患者。此外,该计划导致疲劳严重程度降低、白天嗜睡减少以及认知功能改善。